|
Our findings of high satisfaction among
vacuum constriction device users are quite different from those
reported by Gilbert and Gingell who noted only a 26.7% rate of
"satisfactory intercourse" in 12 of 45 patients with a mean followp
of 9 months. In their study vacuum constriction devices were offered
to men as a second-line treatment option after having failed
intracavernosal pharmacological injection therapy. They further
conclude that only "a small number of patients" will find the vacuum
constriction device useful.
Of our patients treated with prior
injection therapy there was no statistically significant difference
in satisfaction or regular use. The success rate of Gilbert and
Gingell was also low when compared with results of other studies of
patients who failed to achieve success with injection therapy before
vacuum constriction device use. Marmar et al reported results in 22
patients who received intracavernous injections but who failed to
achieve a complete erection. They found that 21 of the 22 patients
achieved a rigid erection with the vacuum constriction device after
only partial tumescence with injection therapy alone. Allen et al
found a 94% positive predictive value of a good response to
papaverine in selecting patients in whom a vacuum device would be
successful. They reported only a 46% initial response with rigidity
satisfactory for intercourse in patients using the vacuum
constriction device but this was improved to 88% with regular use.
Thus, it appears that satisfaction and successful use of the vacuum
constriction device can be expected from patients with a history of
pharmacological intracavernosal injection therapy, including those
who have failed with this form of treatment.
In addition to prior therapy with a
pharmacological erection program, vacuum constriction devices have
proved successful in patients who failed prior penile prosthesis.
Our study included 4 patients who underwent explanation of a failed
penile prosthesis, and all reported satisfactory erections and
regular use of the vacuum constriction device. This finding is in
support of the study by Moul and McLeod who reported a 71% (10 of
14) rate of regular use and 73% rate of patient and partner
satisfaction among patients in whom a penile implant had been
removed before vacuum constriction device use.
They noted that the quality of
erection and satisfaction improved with time, possibly due to the
resolution of corporeal scarring and progressively improved blood
flow into corporeal sinuses.
Satisfaction in terms of hardness, length and circumference was
greater than 90% in both groups. The fact that there was no
significant change in satisfaction with hardness and length between
the 2 groups indicates that rigidity achieved at 3 months is a
reproducible phenomenon, which as durable through 29 months of
average use.
Perhaps the most interesting finding
was in satisfaction (greater than 90%) with regard to penile
circumference. This finding is surprising because the vacuum
constriction device produces a penile diameter greater than that
attained during a normal erection with blood trapped in the
extracorpoeal tissues accounting for these differences.
Few reports on vacuum constriction
device use contain information addressing partner satisfaction.
Responses from both groups indicated greater than 85% partner
satisfaction during intercourse while using the device. Turner et al
reported an increase in partner arousal, ability to achieve orgasm
during inter course and overall greater partner satisfaction.
Our patients were also asked whether the partner had noted any
"coldness" of the penis during intercourse.
Although "coldness" was noted by about a quarter of partners in both
groups, that which decreased partner pleasure was experienced by
only approximately 10% in both groups.
Nadig et al have previously described
a skin temperature change of the penis to decrease gradually an
average of 0.96C (0.5 to 3.1C) in 30 minutes. This decrease is due
to venous pooling of blood and a partial arterial obstruction
created by the vacuum constriction device at the base of the penis.
This finding has been confirmed by Marmar et al who demonstrated a
70 to 75% decrease in the penile brachial artery index using penile
plethysmography during application of the vacuum constriction device
ring. Interestingly, the majority of patients in both groups stated
that this was not a problem.
Vacuum constriction devices have proved to be an effective way to
produce an erection-like state in patients with erectile
dysfunction. Although early success and satisfaction have been
previously reported, few studies address the long-term results in
device use. Our study supports the concept that excellent results in
patient and partner satisfaction as well as early regular use can be
expected to continue with time.
Finally, we have demonstrated a
statistically significant increase in the frequency of successful
intercourse attempts in 79% of the patients using the device for 1
year, which was maintained in 77% beyond the first year.
Despite its limitations, the vacuum
constriction device appears to be an effective and durable
non-operative treatment for erectile dysfunction, and its use should
continue to increase along with its growing patient population.
|